NCT04041453View on ClinicalTrials.gov

Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

October 9, 2019

Primary Completion Date

March 7, 2020

Study Completion Date

March 7, 2020

Conditions
Trichuris InfectionHelminthiasis
Interventions
DRUG

Ivermectin

Ivermectin at 600mcg/kg in addition to albendazole will be provided for 1 or 3 days.

DRUG

Albendazole

Albendazole will be provided as an active control or in experimental arms for 1 or 3 days with ivermectin.

Trial Locations (2)

4530

IIET, Orán

Unknown

Universidad Autónoma de Honduras, Tegucigalpa

All Listed Sponsors
collaborator

Brock University

OTHER

collaborator

Universidad Nacional del Centro de la Provincia de Buenos Aires

OTHER

collaborator

Universidad Nacional Autonoma de Honduras

OTHER

lead

Alejandro Krolewiecki

OTHER

NCT04041453 - Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients | Biotech Hunter | Biotech Hunter